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were challenged by in vivo collagenase treatment, increased staining of
the chondrocytes was seen.
Conclusions: We identiﬁed a genetic variant on chromosome 19 to be
associated with cartilage thickness and hip OA. The variant is located
in a gene showing an expression pattern that supports a role in
chondrogenetic differentiation. GWAS for underlying endophenotypes
might be a proliﬁc route to identify risk loci for complex diseases
such as OA.
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Purpose: Aberrant transcription proﬁling in osteoarthritis(OA) synovial
ﬁbroblasts(SFs) lacking consistent speciﬁc genetic mutations suggests
that epigenetic mechanisms along with the environmental factors
may be involved in its pathogenesis. Compared to those from
normal or rheumatoid arthritis(RA) SFs, over-activated OASFs have an
important role in the destruction of normal joint architecture, and
the imprinted, phenotypical aggressiveness could be determined by
epigenetic mechanism. To investigate a global DNAmethylation of human
OASFs using methylated DNA isolation assay (MeDIA)-CpG promoter
microarray, and compared it with SFs of RA patients or healthy controls
in Korean population.
Methods: Human synovial tissue samples obtained during undergoing
total knee joint replacement surgery in 2 OA and 3 RA patients. 2
Normal synovium was collected by arthroscopic or open knee surgery
of traumatic ligament injury of healthy populations. Total DNA extracted
from SFs using the QIAamp DNA mini and blood kit protocol (Qiagen,
Hilden, Germany). To discover novel hypo- or hypermethylated genes
in OA by genome-wide search, we introduce a MeDIA-coupled CpG
microarray method for directly identifying differentially methylated
regions of the genomes in each pooled synovial cells between OA and RA
patients. The methylation status of promising candidates was validated
by quantitative pyrosequencing assay in each synovial cells.
Results: In two CpG microarray, 4 genes were screened as 5
fold hypomethylated targets among 1,714 porbes. Through stepwise
subtraction processes, we ﬁnally selected four candidate targets. Among
of these targets, two genes, APEX1 gene(gt-OA1) and TGFB1 gene(gt-OA2)
have shown so far a signiﬁcant decrease in the methylation frequency
in OA when compared in independent groups of synovial DNA samples
from OA patients with from RA and normal controls.
Conclusions: APEX1 and TGFB1 gene promoter is hypomethylated in
OASFs than OA and healthy controls. Pathophysiologic correlation and
their role as a diagnostic or prognostic marker should be investigated in
a larger number of patients group hereafter.
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Purpose: The evidence for an association between mutations in HFE
gene related to hemochromatosis and risk of hip or knee osteoarthritis is
inconsistent. Total joint replacement is considered a surrogate measure
for symptomatic end-stage osteoarthritis. This study aimed to examine
the relationship between HFE gene mutations and risk of total hip and
knee replacement in a population-based cohort.
Methods: The Melbourne Collaborative Cohort Study is a prospective
cohort study that commenced recruitment in 1990. Participants born in
Australia, New Zealand, the United Kingdom, or Ireland (n =27,848) were
genotyped for the HFE C282Y variant. Total hip and knee replacements for
osteoarthritis during 2001–2009 were ascertained from the Australian
Orthopaedic Association National Joint Replacement Registry. Hazard
ratios (HRs) and conﬁdence intervals (CIs) were obtained from Cox
regression.
Results: Compared to those with no C282Y variant, C282Y homozygotes
were at increased risk of total hip replacement (HR 1.94, 95% CI 1.04–
3.62). The association was stronger for men (HR 3.34, 95% CI 1.48–7.52)
than for women (HR 1.22, 95% CI 0.46–3.27) (p for interaction = 0.21).
Only 3 C282Y homozygotes had total knee replacements; the HR was
0.51 (95% CI 0.16–1.57). C282Y/H63D compound heterozygosity was not
related to the risk of total hip or knee replacement.
Conclusions: HFE C282Y homozygosity was associated with increased
risk of total hip replacement for osteoarthritis for men but not for
women. The mechanism for this is unknown and the ﬁndings need to
be conﬁrmed in future studies.
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Purpose: To analyze the inﬂuence of the mtDNA haplogroups in the
progression of the osteoarthritis (OA) disease.
Methods: The DNA of 282 knee and/or hip OA samples from Hospital
Universitario A Corun˜a was isolated to obtain their mtDNA haplogroups.
Knee and/or hip radiographs from all these samples were obtained at
two stages of the OA disease of at least 36 months between them,
and evaluated according to the K/L scale from grade 0 to IV. Statistical
analyses included Kaplan-Meier survival curves for each haplogroup or
cluster tested, as well as Cox regression models taking into account
another variables such as gender, haplogroup (or cluster) and body mass
index (BMI).
Results: For this study, two types of progression were established: OA
progression and severity progression. We considered OA progression
when a patient evolved from K/L grade 0-I to K/L grade II-III or K/L
grade IV, and from K/L grade II-III to K/L grade IV, in at least one of the
joints analyzed. The results obtained showed that the OA progression
varies signiﬁcantly according to the mtDNA haplogroups (p = 0.030),
and the main differences were detected when compared patients that
belonged to the cluster TJ (better progressors) with patients of the
cluster KU (worse progressors) (p = 0.083) (Figure 1). On the other hand,
we considered severity progression when a patient evolved to knee
or hip prosthesis from an initial K/L grade III or less. In this case, the
results obtained showed that patients carrying the most common mtDNA
haplogroup H had a worse severity progression than non-H patients
(p = 0.035) (Figure 2). The Cox regression model also showed that males
evolved worse than females (p = 0.028).
Conclusions: The mtDNA haplogroups inﬂuence the progression of OA;
these results strength the role of the mitochondria in the OA disease.
Fig. 1. Kaplan–Meier survival curve showing the different OA progression
between clusters KU and TJ.
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Fig. 2. Kaplan–Meier survival curve showing the different severity
progression between carriers of the haplogroup H and non-H carriers.
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Purpose: Previous epidemiologic studies have demonstrated an
association of low serum 25-hydroxyvitamin D levels with the
development and progression of osteoarthritis (OA) of the hip and knee.
Potential pathophysiologic mechanisms include effects on chondrocyte
metabolism and immune responses as well as associations with low
bone mineral density. A prior genome-wide association study (GWAS)
demonstrated associations of single nucleotide polymorphisms (SNPs)
in genes involved in vitamin D metabolism with serum 25(OH)D
insufﬁciency (Lancet 2010;376:180–8). The present analysis focused on
whether SNPs in genes within the vitamin D metabolism pathway are
associated with radiographic knee OA.
Methods: We tested for associations between radiographic knee
OA (RKOA) and 271 SNPs falling within 6 Vitamin D metabolism
pathway genes (CYP2R1; CYP24A1, CYP27A1, CYP27B1, GC, VDR) in 3286
participants from the Osteoarthritis Initiative (OAI). Cases (N=2209) had
at least one knee with deﬁnite osteophytes irrespective of the presence
of joint space narrowing (equivalent to Kellgren-Lawrence [KL] grade 2
of higher). Controls (N=1077) had both knees free of both osteophytes
and joint space narrowing (equivalent to KL grade 0). The candidate gene
SNPs were genotyped on the Illumina 2.5M platform as part of the GWAS
of OAI participants. Odds ratios for the association of individual SNPs
and RKOA were estimated from logistic regression analyses adjusted for
age and gender; analyses were conducted separately for Caucasians and
African-Americans. We estimated that the sample size would provide
80% power to detect associations with odds ratios of 1.25–1.37 for SNPs
with minor allele frequencies of 0.10 to 0.50 (a = 0.001).
Results: Demographic features of cases and controls are shown in Table 1.
In single SNP analysis of 2,669 Caucasian subjects, RKOA was nominally
associated with 2 SNPs in CYP2R1 (p < 0.05), 1 SNP in VDR (p < 0.02),
and 1 SNP in CYP24A1 (p < 0.02). Using a gene-wise permutation test
that accounted for correlations among SNPs and the number of SNPs
tested within each gene, none of these associations was smaller than
what would have been expected by chance. In single SNP analysis of
617 African-American subjects, RKOA was nominally associated with
2 SNPs in CYP27A1 (p < 0.03), 1 SNP in VDR (p < 0.03), and 2 SNPs in
CYP24A1 (p < 0.03). After performing the gene-wise permutation test,
there remained weak evidence that the association observed between
CYP24A1 SNP20–52212617 and RKOA (p =0.007) was smaller than would
have been observed by chance after taking into account the multiple
testing within this gene (p =0.06).
Conclusion: These are the ﬁrst preliminary results from the Genome
wide association study of participants in the OAI. They suggest that,
despite weak evidence of an association of a single SNP within
the CYP24A1 gene in African-Americans, genes within the vitamin D
metabolism pathway do not appear to inﬂuence the development of
RKOA in U.S. adults.
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Purpose: To chart the genes and processes involved in the breakdown
of cartilage during osteoarthritis (OA) in a genome wide expression
approach of a considerable number (N=33) of matched OA affected and
preserved cartilage samples using microarrays.
Methods: For 33 patients of the research osteoarthritis and articular
cartilage (RAAK) study (mean age 66.2, range 54–80) we collected
paired cartilage samples at joint replacement surgeries. Affected (near
lesion) areas were matched by preserved (distant from lesion) areas
within each single joint. We included both hip (N=22) and knee
(N=11) replacements. By use of microscopic assessment a scoring of
the cartilage damage was made according to Mankin which takes both
cellular and matrix features of OA into account. RNA was isolated by use
of cryogenic disintegration of the cartilage followed by Qiagen column
extraction and checked for quality (RIN > 8.0) and quantity by lab-on-
a-chip techniques before applying the standard protocol for Illumina
microarray measurements on the HT12-v3-microarrays. After micro-
array analyses all 33 sample pairs passed basic quality control. Analysis
of the data was performed using ’R’ and the Limma package identifying
the most signiﬁcantly up- or downregulated single genes, corrected for
multiple testing (Holm’s method).
Results: Although for some samples the preserved areas did show
signs of OA damage, the Mankin grading for cartilage indicated overall
less damage within the preserved areas as compared to the matched
affected cartilage areas. In total, we detected 206 probes (representing
183 genes) which were differentially expressed with a Holm adjusted
P-value <0.05, irrespective of fold changes of expression. Amongst
these were genes associated to inﬂammation, the complement system,
development, matrix associated genes and several genes involved in
neuronal processes.
When we prioritized the data for genes that showed a fold change of
at least 2, we found the expression to be decreased for 5 genes and
increased for 15 genes in affected as compared to matched preserved
cartilage (23 corresponding probes). The markedly up-regulated genes
belong to pathways which are the usual suspects for involvement in
OA being; inﬂammation (prostaglandin E synthase (PTGES), chemokine
ligand 14 (CXCL14)) and developmental or matrix associated genes
(osteopontin (SPP1), frizzled related protein (FRZB), collagen type IX alpha
1 (COL9A1)). More remarkable, we observed extensive and signiﬁcant up-
regulation of the nerve growth factor (NGF) gene.
Conclusions: This is the ﬁrst analysis of micro-array expression data of
a large number of OA affected cartilage samples matched by preserved
cartilage from the same joint. We show differential expression 183 genes
reﬂecting several processes that may mark the ongoing OA process in
human cartilage. Possibly, amongst these genes are potent therapeutic
targets which may be targeted to stop the process of cartilage breakdown.
